(Q37938732)

25 August 2017

1 reference

title

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression (English)

1 reference

Kamilla Woznica Miskowiak

25 August 2017

1 reference

5

Lars V Kessing

0 references

series ordinal

1

object named as

Kamilla W Miskowiak

1 reference

25 August 2017

2

Maj Vinberg

1 reference

25 August 2017

4

Hannelore Ehrenreich

0 references

Catherine J. Harmer

object named as

Catherine J Harmer

series ordinal

3

0 references

publication date

23 September 2011

1 reference

25 August 2017

number of pages

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

25 August 2017

volume

219

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

687-698

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-011-2511-1

25 August 2017

exact match

0 references

cites work

Erythropoietin enhances hippocampal long-term potentiation and memory

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Potential role for adult neurogenesis in the encoding of time in new memories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Persistent non-verbal memory impairment in remitted major depression - caused by encoding deficits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

A longitudinal analysis of neurocognitive function in unipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Chronic stress in adulthood followed by intermittent stress impairs spatial memory and the survival of newborn hippocampal cells in aging animals: prevention by FGL, a peptide mimetic of neural cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Emerging biological roles for erythropoietin in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Facial expressions and complex IAPS pictures: common and differential networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin: a multimodal neuroprotective agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Brain activity underlying encoding and retrieval of source memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

When is adult hippocampal neurogenesis necessary for learning? evidence from animal research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Simulated apoptosis/neurogenesis regulates learning and memory capabilities of adaptive neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Cerebral tissue repair and atrophy after embolic stroke in rat: a magnetic resonance imaging study of erythropoietin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neural plasticity to stress and antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin improves operant conditioning and stability of cognitive performance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Intranasal erythropoietin therapy in nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neural substrates of increased memory sensitivity for negative stimuli in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Antidepressant drug action: a neuropsychological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Acute SSRI administration affects the processing of social cues in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Antidepressant drug treatment modifies the neural processing of nonconscious threat cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neurogenesis and depression: breakthrough or blind alley?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

The erythropoietin receptor in normal and cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Cognitive impairment in the euthymic phase of affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Spatial performance and corticosteroid receptor status in the 21-day restraint stress paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Comparison of the effects of erythropoietin and its carbamylated derivative on behaviour and hippocampal neurogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Impaired recognition of facial emotion in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Beneficial effect of erythropoietin on experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neuroplasticity and cellular resilience in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Glucocorticoids, depression, and mood disorders: structural remodeling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin enhances hippocampal response during memory retrieval in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Have no fear, erythropoietin is here: erythropoietin protects fear conditioning performances after functional inactivation of the amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin improves place learning in fimbria-fornix-transected rats and modifies the search pattern of normal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Depression, chronic diseases, and decrements in health: results from the World Health Surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Cognitive impairment in the euthymic phase of chronic unipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Normalizing hematocrit in dialysis patients improves brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neural systems for orienting attention to the location of threat signals: an event-related fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Cognitive deficits in the euthymic phase of unipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

In vivo evidence that erythropoietin protects neurons from ischemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Antidepressant-induced jitteriness/anxiety syndrome: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Neonatal treatment with TRH affects development, learning, and emotionality in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Evidence for continuing neuropsychological impairments in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Effect of erythropoietin on oxygen-induced brain injury in the newborn rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Chronic restraint stress impairs neurogenesis and hippocampus-dependent fear memory in mice: possible involvement of a brain-specific transcription factor Npas4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2511-1

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

12 December 2020

Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury

1 reference

12 December 2020

Erythropoietin gene expression in human, monkey and murine brain.

1 reference

12 December 2020

Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia

1 reference

12 December 2020

Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia.

1 reference

12 December 2020

Erythropoietin: structure, control of production, and function

1 reference

12 December 2020

Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration

1 reference

12 December 2020

Current status of antidepressants: clinical pharmacology and therapy

1 reference

12 December 2020

Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well?

1 reference

12 December 2020

Erythropoietin enhances neurological recovery after experimental spinal cord injury

1 reference

12 December 2020

Neuroimaging Abnormalities in the Amygdala in Mood Disorders

1 reference

12 December 2020

Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

1 reference

12 December 2020

Studies on erythropoiesis. VII. The role of the kidney in the production of erythropoietin

1 reference

12 December 2020

Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance.

1 reference

12 December 2020

Erythropoietin improves neurodevelopmental outcome of extremely preterm infants.

1 reference

12 December 2020

The role of the hippocampus in the pathophysiology of major depression

1 reference

12 December 2020

Erythropoietin: a candidate compound for neuroprotection in schizophrenia

1 reference

12 December 2020

10.1007/S00213-011-2511-1

Identifiers

DOI

1 reference

25 August 2017

1 reference